The two organizations have been in talks since January, the month the Harrington board voted to sign a letter of intent to pursue a deal with UMass Memorial.
UMass Memorial and Harrington said the regulatory review process is expected to take up to four months. The deal will be reviewed by the Massachusetts Health Policy Commission and the Massachusetts Attorney General’s Office.
Read the Worcester Business Journal article here.
More articles on healthcare industry transactions:
For-profit hospital M&A update: 14 deals involving CHS, Tenet and HCA
Philadelphia health system merger clears latest FTC challenge
Illinois system to merge with Northwestern Medicine
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
